One day busulfan (Bu) and high dose of cyclophosphamide (Cy) as preparative regimen for bone marrow transplantation (BMT) in patients with severe aplastic anemia (SAA).

被引：0
|
作者：
Pallotta, RS [1 ]
Macedo, MCMA [1 ]
Saboya, R [1 ]
Dzik, C [1 ]
Silva, RL [1 ]
Loterio, H [1 ]
Massumoto, CM [1 ]
Chamone, DAF [1 ]
Dulley, FL [1 ]
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,FDN SANGUE HEMOCTR,BMT PROGRAM,SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4507 / 4507
页数：1
相关论文
共 50 条
  • [41] Bone marrow transplantation (BMT) or immunosuppressive therapy (IS) for patients with severe aplastic anemia (SAA). A report of the European Group for Blood and Marrow Transplants (EBMT) SAA Working Party
    Bacigalupo, A
    Brand, R
    Socie, G
    Passy, J
    Locasciulli, A
    Van Lint, MT
    Tichelli, A
    McCann, S
    Marsh, J
    Ljundgman,
    Hows, J
    Marin, P
    Schrezenmeier, H
    BONE MARROW TRANSPLANTATION, 1998, 21 : S49 - S49
  • [42] Addition of antithymocyte globulin (ATG) to cyclophosphamide (Cy) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anemia (SAA): Results of a randomized controlled trial.
    Champlin, RE
    Perez, WS
    Passweg, J
    Klein, JP
    Camitta, BM
    Gluckman, E
    Bredeson, C
    Horowitz, MM
    BLOOD, 2003, 102 (11) : 80A - 80A
  • [43] Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia
    H J Kang
    H Y Shin
    H S Choi
    H S Ahn
    Bone Marrow Transplantation, 2004, 34 : 939 - 943
  • [44] Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia
    Kang, HJ
    Shin, HY
    Choi, HS
    Ahn, HS
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 939 - 943
  • [45] BONE-MARROW TRANSPLANTATION (KMT) IN SEVERE APLASTIC-ANEMIA (SAA)
    KOS, M
    HINTERBERGER, W
    HOCKER, P
    SCHMIDMEIER, W
    GEISSLER, K
    HINTERBERGER, M
    SCHWARZINGER, I
    HAJEKROSENMAYR, A
    VOLCPLATZER, B
    NEUMANN, E
    NIESSNER, H
    ACTA MEDICA AUSTRIACA, 1986, 13 : 75 - 75
  • [46] Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation
    Brodsky, RA
    Sensenbrenner, LL
    Jones, RJ
    BLOOD, 1996, 87 (02) : 491 - 494
  • [47] Analyses of hematopoietic recovery after graft rejection in patients (PTS) submitted to bone marrow transplantation (BMT) for severe aplastic anemia (SAA).
    Bitencourt, MA
    deMedeiros, CR
    Friedrich, ML
    Ribeiro, EF
    Alonso, CA
    Pereira, NF
    Cavalli, IJ
    Pasquini, R
    BLOOD, 1996, 88 (10) : 456 - 456
  • [48] Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
    F L Dulley
    A C Vigorito
    F J P Aranha
    D Sturaro
    M A Ruiz
    R Saboya
    M C M A Macedo
    R L Da Silva
    D A F Chamone
    J Mehta
    A Bacigalupo
    C A De Souza
    Bone Marrow Transplantation, 2004, 33 : 9 - 13
  • [49] Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
    Dulley, FL
    Vigorito, AC
    Aranha, FJP
    Sturaro, D
    Ruiz, MA
    Saboya, R
    Macedo, MCMA
    Da Silva, RL
    Chamone, DAF
    Mehta, J
    Bacigalupo, A
    De Souza, CA
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 9 - 13
  • [50] HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE AS THE PRIMARY PREPARATIVE REGIMEN FOR MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA
    URBAN, EC
    KROISEL, P
    BONE MARROW TRANSPLANTATION, 1987, 2 (02) : 217 - 218
12345